The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2015

Filed:

Nov. 10, 2010
Applicants:

Maria Chiara Bonini, Peschiera Borromeo, IT;

Pietro Genovese, Messina, IT;

Philip D. Gregory, Orinda, CA (US);

Michael C. Holmes, Oakland, CA (US);

Luigi Naldini, Pioltello, IT;

David Paschon, Oakland, CA (US);

Elena Provasi, Cislago, IT;

Lei Zhang, Davis, CA (US);

Inventors:

Maria Chiara Bonini, Peschiera Borromeo, IT;

Pietro Genovese, Messina, IT;

Philip D. Gregory, Orinda, CA (US);

Michael C. Holmes, Oakland, CA (US);

Luigi Naldini, Pioltello, IT;

David Paschon, Oakland, CA (US);

Elena Provasi, Cislago, IT;

Lei Zhang, Davis, CA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); C12P 21/06 (2006.01); C07H 21/04 (2006.01); A61K 35/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/22 (2013.01); A61K 35/00 (2013.01); A61K 38/00 (2013.01); C07K 2319/81 (2013.01); C07K 2319/95 (2013.01);
Abstract

Disclosed herein are methods and compositions for inactivating TCR genes, using zinc finger nucleases (ZFNs) comprising a zinc finger protein and a cleavage domain or cleavage half-domain in conditions able to preserve cell viability. Polynucleotides encoding ZFNs, vectors comprising polynucleotides encoding ZFNs and cells comprising polynucleotides encoding ZFNs and/or cells comprising ZFNs are also provided. Disclosed herein are also methods and compositions for expressing a functional exogenous TCR in the absence of endogenous TCR expression in T lymphocytes, including lymphocytes with a central memory phenotype. Polynucleotides encoding exogenous TCR, vectors comprising polynucleotides encoding exogenous TCR and cells comprising polynucleotides encoding exogenous TCR and/or cells comprising exogenous TCR are also provided.


Find Patent Forward Citations

Bonini, Maria. (2015). Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases (U.S. Patent No. 8956828). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8956828

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…